Life Biosciences

Life Biosciences on fru.dev

• Frontier tech

Life Biosciences across fru.dev: timeline

1. 2026-06-09 First patient dosed with partial reprogramming therapy ER-100 (Emerging)
2. 2026-04-08 Life Biosciences: Series D $80M (Emerging)
3. 2026-01-28 FDA clears IND for Life Biosciences' reprogramming therapy ER-100 (Emerging)

Sources

• emerging.fru.dev/companies/life-biosciences